mitotane has been researched along with Heavy Menstrual Bleeding in 1 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
Excerpt | Relevance | Reference |
---|---|---|
"Adrenocortical carcinoma is a rare tumour with high malignancy and poor prognosis." | 5.46 | Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane. ( Czuczwar, P; Paszkowski, T; Szkodziak, F; Szkodziak, PR; Woźniak, S, 2017) |
"Adrenocortical carcinoma is a rare tumour with high malignancy and poor prognosis." | 1.46 | Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane. ( Czuczwar, P; Paszkowski, T; Szkodziak, F; Szkodziak, PR; Woźniak, S, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Szkodziak, PR | 1 |
Czuczwar, P | 1 |
Woźniak, S | 1 |
Szkodziak, F | 1 |
Paszkowski, T | 1 |
1 other study available for mitotane and Heavy Menstrual Bleeding
Article | Year |
---|---|
Use of a levonorgestrel-releasing intrauterine device for menorrhagia treatment during adjuvant therapy of adrenocortical carcinoma with mitotane.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Agents, Hormonal; Chemothe | 2017 |